Which lipid-lowering medication class requires baseline and periodic assessment of liver enzymes and monitoring for muscle pain due to rhabdomyolysis risk?

Answer and explanation

Correct answer: D. HMG-CoA reductase inhibitors

Answer: HMG-CoA reductase inhibitors.
Why not the others: Statins (HMG-CoA reductase inhibitors) carry well-documented risks of myopathy, elevated creatine kinase, and rhabdomyolysis; Bile acid sequestrants act locally in the intestinal lumen; Ezetimibe has lower myopathy incidence unless combined with statins; Omega-3 esters primarily lower triglycerides without causing myositis.

Practise more Applied Clinical Pharmacology, Dosages and Fluid Balance.

Free questions with an explanation for every one, and full timed MOH Prometric mock tests.